Advertisement
UK markets closed

  • FTSE 100

    8,173.80
    +52.56 (+0.65%)
     

  • FTSE 250

    20,026.87
    +100.28 (+0.50%)
     

  • AIM

    768.36
    +3.38 (+0.44%)
     

  • GBP/EUR

    1.1680
    -0.0004 (-0.04%)
     

  • GBP/USD

    1.2500
    -0.0024 (-0.19%)
     

  • Bitcoin GBP

    47,488.52
    +1,826.70 (+4.00%)
     

  • CMC Crypto 200

    1,278.85
    +8.11 (+0.64%)
     

  • S&P 500

    5,033.41
    +15.02 (+0.30%)
     

  • DOW

    38,039.08
    +135.79 (+0.36%)
     

  • CRUDE OIL

    78.76
    -0.24 (-0.30%)
     

  • GOLD FUTURES

    2,313.40
    +2.40 (+0.10%)
     

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

  • HANG SENG

    18,207.13
    +444.10 (+2.50%)
     

  • DAX

    17,921.75
    -10.42 (-0.06%)
     

  • CAC 40

    7,925.53
    -59.40 (-0.74%)
     
Money:

Best UK mortgage deals of the week

The cheapest home loans available now

Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024

PR Newswire
·1-min read

ALAMEDA, Calif., April 9, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2024 after market close on Tuesday, May 7, 2024 at 4:30 PM Eastern Time. A press release with first quarter 2024 financial results will be issued after market close that day.

Penumbra, Inc. Logo (PRNewsFoto/Penumbra, Inc.)
Penumbra, Inc. Logo (PRNewsFoto/Penumbra, Inc.)

Webcast & Conference Call Information
The conference call can be accessed live over the phone by dialing (888) 596-4144 (conference id: 7567226), or the webcast can be accessed on the "Events and Presentations" section under the "Investors" tab of the Company's website at www.penumbrainc.com. The webcast will be available on the Company's website for at least two weeks following the completion of the call.

About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn.

ADVERTISEMENT

Investor Relations

Penumbra, Inc.
510-995-2461
investors@penumbrainc.com

 

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-schedules-first-quarter-2024-earnings-release-and-conference-call-for-may-7-2024-302108911.html

SOURCE Penumbra, Inc.